Abstract

Cancer is the second leading cause of death worldwide. Cisplatin has challenged cancer treatment; however, resistance and side effects hamper its use. New agents displaying improved activity and more reduced side effects relative to cisplatin are needed. In this work we present the synthesis, characterization and biological activities of three complexes with quinoline-substituted 2,2':6',2″-terpyridine ligand: [Pt(4'-(2-quin)-terpy)Cl](SO3CF3) (1), [Au(4'-(2-quin)-terpy)Cl](PF6)2·CH3CN (2) and [Cu(4'-(2-quin)-terpy)Cl](PF6) (3). The three complexes displayed a high antiproliferative activity in ovarian carcinoma cell line (A2780) and even more noticeable in a colorectal carcinoma cell line (HCT116) following the order 3>2>1. The complexes IC50 are at least 20×lower than the IC50 displayed by cisplatin (15.4μM) in HCT116cell line while displaying at the same time, much reduced cytotoxicity in a normal dermal fibroblast culture. These cytotoxic activities seem to be correlated with the inclination angles of 2-quin unit to the central pyridine. Interestingly, all complexes can interact with calf-thymus DNA (CT-DNA) invitro via different mechanisms, although intercalation seems to be the preferred mechanism at least for 2 and 3at higher concentrations of DNA. Moreover, circular dichroism (CD) data seems to indicate that complex 3, more planar, induces a high destabilization of the DNA double helix (shift from B-form to Z-form). Higher the deviation from planar, the lower the cytotoxicity displayed by the complexes. Cellular uptake may be also responsible for the different cytotoxicity exhibited by complexes with 3>2 >1. Complex 2 seems to enter cells more passively while complex 1 and 3 might enter cells via energy-dependent and -independent mechanisms. Complexes 1-3 were shown to induce ROS are associated with the increased apoptosis and autophagy. Moreover, all complexes dissipate the mitochondrial membrane potential leading to an increased BAX/BCL-2 ratio that triggered apoptosis. Complexes 2 and 3 were also shown to exhibit an anti-angiogenic effect by significantly reduce the number of newly formed blood vessel in a CAM model with no toxicity in this invivo model. Our results seem to suggest that the increased cytotoxicity of complex 3 in HCT116cells and its potential interest for further translation to pre-clinical mice xenografts might be associated with: 1) higher % of internalization of HCT116cells via energy-dependent and -independent mechanisms; 2) ability to intercalate DNA and due to its planarity induced higher destabilization of DNA; 3) induce intracellular ROS that trigger apoptosis and autophagy; 4) low toxicity in an invivo model of CAM; 5) potential anti-angiogenic effect.

Highlights

  • The complexes IC50 are at least 20 Â lower than the IC50 displayed by cisplatin

  • Higher the deviation from planar, the lower the cytotoxicity displayed by the complexes

  • The results show a significant dissipation of the mitochondrial membrane potential in HCT116 cells exposed to the complexes 1e3 for 48 h (Fig. 11), These results agree with previous data from BAX/ BCL2 ratio (Fig. 10) and that exposure to complexes 1e3 trigger apoptosis through the intrinsic pathway [99]

Read more

Summary

Introduction

A biologically active molecule can interact with DNA strand in covalent (via alkylation or inter- and intrastrand crosslinking, like cisplatin and its analogues) and noncovalent mode e by groove binding (facilitated by van der Waals interactions and hydrogen bonding), intercalation (stabilized by pp stacking interactions between the drug and DNA bases) or external binding (electrostatic outside-edge stacking interactions) [8e14]. Complexes containing redox-active metals may undergo both interaction with DNA and redox reactions, which allow them to interact with other biological molecules [15]. In order to get further insights into the role of metal center and ligand substitution in square-planar coordination compounds, we have synthetized and investigated the molecular structures and antiproliferative properties of three new complexes (Scheme 1) with 2,20:60,200-terpyridine (terpy) ligand functionalized with 2quinolinyl (2-quin). With reference to the previous results concerning biologically active transition metal complexes bearing terpy-based ligands [3,5,13,17e28], searching new efficient anticancer agents in this group seems to be justifiable. Chelating ability of terpy ligands enhances the complex stability, while their planarity promotes intercalative interaction of the complex with DNA due to pstacking between the plane of the aromatic rings and DNA base pairs

Synthesis and characterization
Solid state structures of 1e3
UVevis spectroscopy studies
DNA binding
Biological activity
Determination of BAX and BCL-2 protein expression by western-blot
Conclusions
Materials
Synthesis
Instrumentation
X-ray crystallography
Spectroscopy and stability
DNA-binding
Biological studies
Viability assays Cells were cultivated in 96-well plates at a density of
Statistical analysis
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call